Course Code: REL-ACU-0-ADCT
Hours: 1
Type: Online Course
Content Expiration Date: 12/31/2025
Learning Objectives:
Recall the pathophysiology of the adaptive immune system vs. the innate immune system and potential causes of autoimmune diseases.
Identify common autoimmune diseases, complications related to autoimmune diseases, various treatment approaches, and the impact of COVID-19 and other viruses on autoimmune dysfunction.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Autoimmune Disease Overview
The Current State of Autoimmune Diseases
Incidence & Prevalence
The Immune System: A Complex Orchestrated Pathophysiology
Causes of Autoimmune Diseases
Section 3: Common Rheumatic Autoimmune Diseases
Rheumatoid Arthritis (RA)
Systemic Lupus Erythematosus (SLE)
Primary Sjögren Syndrome (pSS)
Systemic Autoinflammatory Diseases (SAIDs)
Section 4: Autoimmune Diseases Treated by Other Specialists
Endocrinology
Neurology
Gastroenterology
Dermatology
Section 5: Rheumatic Autoimmune & SAID Treatment Classes
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Steroids
Conventional Disease-Modifying Anti-Rheumatic Drugs (cDMARDs)
Other DMARDs: Immunosuppressive Agents
Antimalarial Drugs
Biologics
Immunoglobulin Replacement
Section 6: Current Topics
COVID-19: Autoimmune & SAID Implications
Vaccine Safety & the Autoimmune Population
Section 7: Healthcare Implications & Care Management Recommendations
Healthcare Implications
Section 8: Clinical Vignette
Section 9: Conclusion
Course Summary
Course Contributors
References
Instructor: Shalla Newton, MSN, RN, NE-BC
Shalla is a subject matter expert (SME)/writer for Relias. She completed her BSN and two undergraduate degrees with top honors from the University of Wisconsin-Madison. Shalla earned her dual MSN degrees from Johns Hopkins University with top honors. She also maintains her post-baccalaureate nurse educator certificate (NE-BC). Shalla’s tenure spans over 20 years of cross-functional leadership and direct clinical roles in healthcare, biopharma/biotech, government affairs, managed care/market access, nonprofit patient advocacy, and research. Her subject matter expertise is in rare, orphan, and complex diseases. Her sub-expertise is in immune-mediated diseases (rheumatology and immunology), genetics, neurology, hematology/oncology, several pediatric diseases, population/public health, and larger systemic healthcare affairs. Shalla is a published author with leading rare disease experts and a global speaker. She also sits on scientific, advocacy, and legislative advisory boards. She has led national advocacy and disease awareness campaigns, including speaking before congress, leading to the first-in-class rare disease biologic approval and investigative treatment protocols.
Writer: Laura Bell, BSN, RN, CCRN
Laura Bell, BSN, RN, CCRN is a SME writer for Relias with over 16 years of acute care experience in nursing. She began working in adult critical care at WakeMed Cary Hospital in 2011, obtained her CCRN certification in 2016, and served in the role of Rapid Response/Code Blue/Rounding RN for over 2 years. She continues to work as a staff nurse in the intensive care unit. Laura has a passion for education and excellence in nursing care. She has been involved in numerous special projects and educational activities to improve staff development, evidence-based clinical practice, and patient satisfaction. She continues to strive for excellence in education and clinical development as an acute care course writer.
Target Audience:
The target audience for this course is: Educators; Intermediate level Occupational Therapist; Nursing Personnel; in the following settings: Hospitals: Acute.
Relias Learning will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Relias Learning has a grievance policy in place to facilitate reports of dissatisfaction. Relias Learning will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias Learning at support@reliaslearning.com.
All courses offered by Relias Learning, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Course Delivery Method and Format
Asynchronous Distance Learning with interactivity which includes quizzes with questions/answers, and posttests.